Neoparmi (შპს ნეოფარმი)

Ratio	2018	2019	2020	2021	2022	2023	2024
Margins
Gross Margin	39.1%	39.7%	38.6%	41.1%	51.3%	32.8%	34.3%
EBITDA Margin	8.4%	7.2%	8.8%	9.6%	16.8%	-8.5%	-2.0%
EBITDAR	1,479	1,603	2,242	2,470	3,972	-524	330
EBITDAR Margin	12.5%	12.0%	13.5%	14.7%	21.5%	-3.4%	1.7%
EBIT Margin	7.6%	6.4%	8.1%	9.0%	16.1%	-9.5%	-2.7%
Net Profit Margin	8.2%	6.2%	7.9%	8.8%	13.4%	-9.5%	-3.1%
Operating Expense % of Sales	30.7%	32.5%	29.8%	31.5%	34.5%	41.3%	36.2%
Returns
Return on Assets (ROA)	20.8%	15.5%	20.2%	21.4%	27.6%	-17.0%	-7.4%
Return on Equity (ROE)	30.4%	23.4%	30.5%	28.0%	36.2%	-23.8%	-11.6%
ROIC [EBIT / Invested Capital]	28.3%	24.3%	32.8%	30.0%	47.6%	-26.2%	-10.8%
Leverage & debt balances
Debt-to-Assets	6.6%	6.5%	3.6%	1.3%	0.6%	0.3%	0.0%
Debt-to-Equity	0.10x	0.10x	0.05x	0.02x	0.01x	0.00x	0.00x
Debt-to-EBITDA	0.31x	0.37x	0.16x	0.06x	0.02x	N/A	N/A
Equity-to-Assets	68.5%	66.3%	66.4%	76.7%	76.4%	71.5%	63.7%
Net Debt	-33	-25	-183	-222	-602	-535	-264
Cash & Equivalents	340	378	412	314	658	557	264
Total Debt	307	353	229	92	55	22	N/A
Liquidity & working capital
Current Ratio	3.35x	3.17x	3.27x	3.88x	3.80x	2.51x	1.91x
Quick Ratio	3.35x	0.53x	0.44x	0.59x	3.80x	2.51x	1.91x
Cash Ratio	0.32x	0.28x	0.25x	0.21x	0.32x	0.23x	0.09x
Total Current Assets	3,547	4,253	5,457	5,860	7,830	6,046	5,533
Total Current Liabilities	1,060	1,341	1,669	1,512	2,062	2,410	2,894
Inventory	N/A	3,545	4,725	4,966	N/A	N/A	N/A
Trade Receivables	238	263	171	505	1,215	224	242
Trade Payables	829	1,142	1,477	1,171	895	1,242	1,581
Net Working Capital	2,487	2,912	3,788	4,348	5,767	3,636	2,639
Net Working Capital % of Revenue	21.1%	21.7%	22.8%	25.8%	31.2%	23.7%	13.8%
Trade Working Capital	-591	2,666	3,419	4,300	320	-1,018	-1,338
Trade Working Capital % of Revenue	-5.0%	19.9%	20.6%	25.5%	1.7%	-6.6%	-7.0%
Change in Trade Working Capital	N/A	3,257	754	880	-3,980	-1,338	-320
Turnover & efficiency
Inventory Turnover	N/A	2.28x	2.16x	2.00x	N/A	N/A	N/A
Days Inventory Outstanding (DIO)	N/A	160.0	169.3	182.8	N/A	N/A	N/A
Receivables Turnover	49.59x	50.86x	96.80x	33.35x	15.19x	68.54x	79.16x
Days Sales Outstanding (DSO)	7.4	7.2	3.8	10.9	24.0	5.3	4.6
Payables Turnover	8.66x	7.08x	6.90x	8.47x	10.05x	8.31x	7.98x
Days Payable Outstanding (DPO)	42.1	51.6	52.9	43.1	36.3	43.9	45.7
Cash Conversion Cycle	-34.8 days	115.6 days	120.2 days	150.6 days	-12.3 days	-38.6 days	-41.1 days
Asset Turnover	2.53x	2.49x	2.57x	2.45x	2.06x	1.80x	2.41x
Cash flow & dividends
Operating Cash Flow	41	40	32	-100	423	-99	-289
Free Cash Flow (OCF − Capex proxy)	41	40	32	-100	423	-99	-289
Cash Conversion (OCF / EBITDA)	4.1%	4.1%	2.2%	-6.2%	13.6%	N/A	N/A
Dividends Declared	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividend Payout Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.

Neoparmi

Shareholders

Group structure

Directors & board

Key statistics

About

Revenue & margins

Financial statements

Ownership & group structure

Shareholders

Group structure

Directors & board

Peers